Page last updated: 2024-12-05

1-tridecanol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-Tridecanol, also known as n-tridecanol or 1-tri-decanol, is a **straight-chain fatty alcohol** with the chemical formula CH₃(CH₂)₁₂OH.

Here's why it's important in research:

* **Surfactant Properties:** 1-Tridecanol is a **surfactant**, meaning it can reduce surface tension between liquids or between a liquid and a solid. This property makes it useful in:
* **Emulsions:** Stabilizing mixtures of oil and water.
* **Cosmetics and Detergents:** Improving their cleaning and foaming abilities.
* **Biomedical Research:** Studying cell membranes and drug delivery.

* **Industrial Applications:**
* **Plasticizers:** Making plastics more flexible and less brittle.
* **Lubricants:** Reducing friction between moving parts.
* **Biodiesel:** As a potential component in biodiesel production.

* **Model System:** 1-Tridecanol is often used as a **model system** to study:
* **Lipid Bilayers:** The structure and behavior of cell membranes.
* **Self-Assembly:** How molecules spontaneously organize into complex structures.

* **Research Focus Areas:**
* **Drug Delivery:** Studying how 1-Tridecanol can enhance drug absorption and penetration.
* **Nanomaterials:** Understanding the role of 1-Tridecanol in the formation and properties of nanoparticles.
* **Environmental Science:** Investigating the potential environmental impact of 1-Tridecanol.

In summary, 1-Tridecanol is a versatile molecule with applications in various fields. Its unique properties and potential applications make it a valuable tool for scientific research and industrial development.

1-tridecanol: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

tridecan-1-ol : A long-chain primary fatty alcohol that is tridecane substituted by a hydroxy group at position 1. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

tridecanol : A fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of thirteen carbon atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8207
CHEMBL ID24832
CHEBI ID34123
SCHEMBL ID20879
MeSH IDM0145471

Synonyms (65)

Synonym
BIDD:ER0306
STL287936
tridecyl alcohol
wln: q13
n-tridecanol
nsc5252
tridecanol
112-70-9
nsc-5252
n-tridecyl alcohol
n-tridecan-1-ol
1-tridecanol
tridecan-1-ol
1-tridecanol, 97%
NCGC00164019-01
ai3-35264
einecs 203-998-8
ccris 8591
nsc 5252
brn 1739991
hsdb 5574
MAYBRIDGE1_004320
80206-82-2
85AD1334-FDF8-446D-BF63-A7EE6B26FE07
chebi:34123 ,
CHEMBL24832
HMS553M10
T0803
26248-42-0
LMFA05000171
AKOS005267216
NCGC00164019-02
NCGC00164019-03
unii-8i9428h868
8i9428h868 ,
NCGC00254162-01
cas-112-70-9
dtxcid901947
tox21_202208
NCGC00259757-01
tox21_300138
dtxsid2021947 ,
FT-0608320
einecs 279-420-3
tridecyl alcohol [inci]
1-tridecanol [hsdb]
SCHEMBL20879
1-hydroxytridecane
mfcd00004756
J-002821
1-tridecanol, purum, >=98.0% (gc)
J-016351
CS-W004293
F0001-0261
SY049489
BS-14333
Q161684
AMY5938
H10847
n-tridecyl-d27 alcohol
A894533
BBA24842
EN300-1841776
BP-28084
HY-W004293
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
tridecanolA fatty alcohol consisting of a hydroxy function at any position of an unbranched saturated chain of thirteen carbon atoms.
long-chain primary fatty alcoholA long-chain fatty alcohol in which the hydroxy group is attached to a methylene (CH2) group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (10)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency61.43950.007215.758889.3584AID1224835
AR proteinHomo sapiens (human)Potency1.23340.000221.22318,912.5098AID743042
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.26560.000214.376460.0339AID720691
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency52.38240.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency19.06280.000817.505159.3239AID1159531
farnesoid X nuclear receptorHomo sapiens (human)Potency46.72540.375827.485161.6524AID588526; AID743217
estrogen nuclear receptor alphaHomo sapiens (human)Potency41.10840.000229.305416,493.5996AID743079; AID743080; AID743091
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency39.00260.001723.839378.1014AID743083
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.07940.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency45.91740.000627.21521,122.0200AID651741; AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID1101855Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 48 hr by microdilution method2002Journal of agricultural and food chemistry, Jul-03, Volume: 50, Issue:14
Molecular design of antifungal agents.
AID1081323Nematicidal activity against Bursaphelenchus xylophilus at 0.5 mg/ml measured after 48 hr under microscope2010Journal of agricultural and food chemistry, Feb-10, Volume: 58, Issue:3
Structure-activity relationship of aliphatic compounds for nematicidal activity against pine wood nematode (Bursaphelenchus xylophilus).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (11.11)18.7374
1990's3 (33.33)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.94 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index57.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]